New study reveals anti-cancer properties in Kencur ginger
A Southeast Asian ginger, could be a potential component for new anti-cancer markers
- Date:
- August 28, 2023
- Source:
- Osaka Metropolitan University
- Summary:
- Scientists have verified the anticancer effects of Kencur, a tropical plant of the ginger family, mainly grown in Southeast Asia, in cell and animal experiments. They found that Kencur extract and its main active components significantly inhibit cancer cell growth at the cellular and animal levels. Furthermore, the involvement of TFAM in the mechanism of action was confirmed.
- Share:
You may know it as an aromatic spice to add flavor to your dishes or as a soothing herbal remedy to use for upset stomachs, but researchers from Osaka Metropolitan University have uncovered promising findings that Kencur, a tropical plant in the ginger family native to Southeast Asia, possesses anti-cancer effects.
Led by Associate Professor Akiko Kojima of the Graduate School of Human Life and Ecology, the researchers demonstrated that Kencur extract and its main active component, ethyl p-methoxycinnamate (EMC), significantly suppressed cancer cell growth at the cellular and animal levels.
While previous studies on EMC indicated its anti-cancer potential by decreasing the expression of mitochondrial transcription factor A (TFAM), which is associated with cancer cell proliferation, the exact mechanism remained unclear until now.
"The results of this study confirm the anti-cancer effects of Kencur extract and its main active ingredient, EMC. It is highly expected that TFAM will become a new marker for anti-cancer effects in the future as research advances in related fields," Professor Kojima stated.
Their findings were published in Heliyon.
Story Source:
Materials provided by Osaka Metropolitan University. Note: Content may be edited for style and length.
Journal Reference:
- Yutaro Sasaki, Toshio Norikura, Isao Matsui-Yuasa, Ritsuko Fujii, Leenawaty Limantara, Akiko Kojima-Yuasa. Kaempferia galanga L. extract and its main component, ethyl p-methoxycinnamate, inhibit the proliferation of Ehrlich ascites tumor cells by suppressing TFAM expression. Heliyon, 2023; 9 (6): e17588 DOI: 10.1016/j.heliyon.2023.e17588
Cite This Page: